<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03719820</url>
  </required_header>
  <id_info>
    <org_study_id>HRMRI II</org_study_id>
    <nct_id>NCT03719820</nct_id>
  </id_info>
  <brief_title>Stroke Imaging Package Study of Intracranial Atherosclerosis ( SIPS-ICAS )</brief_title>
  <acronym>SIPS-ICAS</acronym>
  <official_title>Stroke Imaging Package Study of Intracranial Atherosclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wei-Hai Xu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>General Hospital of Chinese Armed Police Forces</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>General Hospital of Shenyang Military Region</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Subei People's Hospital of Jiangsu Province</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fujian Medical University Union Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tangshan Gongren Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Third Affiliated Hospital, Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Qingdao Municipal Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>West China Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Tong Ren Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of University of South China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>JiNing NO.1 People Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tongji Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The University of HongKong-Shenzhen Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Anzhen Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Peking University International Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Tongren Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>China-Japan Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Peking University First Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Chao Yang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Qilu Hospital of Shandong University (Qingdao)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shandong Provincial Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Second Hospital of Hebei Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hebei General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital of Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>China-Japan Union Hospital, Jilin University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zhejiang Provincial Tongde Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>People's Hospital of Ningxia Hui Autonomous Region</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Taiyuan Central Hospital of Shanxi Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hong Xinglong Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Changzhi People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Weihai Municipal Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The first hospital affiliated to AMU (Southwest Hospital)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Affiliated Taihe Hospital of Hubei University of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nanshi Hospital of Nanyang</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Peking Union Medical College Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, multicenter, cohort study to explore the stroke mechanisms of symptomatic
      intracranial atherosclerosis, the dynamic changes under aggressive medical treatment and
      their associations with clinical events using conventional MRI sequences plus high-resolution
      magnetic resonance (HR-MRI).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. First-ever stroke patients attributed to intracranial artery stenosis (&gt; 50% or
           occlusion) within 7 days after onset will be prospectively enrolled in our study and
           undergo new imaging technique package assessment at baseline.

        2. The imaging technique package includes conventional cranial MRI （T1,T2,T2 FLAIR,DWI),
           cranial magnetic resonance angiography (MRA),high-resolution magnetic resonance (HR-MRI)
           and susceptibility weighted imaging (SWI) or T2*-weighted imaging.

        3. Enrolled patients are recommended to receive aggressive medical management consisted of
           Aspirin (100 mg daily) and Clopidogrel (75 mg daily) for 3 months and Rosuvastatin (20mg
           daily) for at least 6 months as well as traditional risk factors management.

        4. Patients were followed up for mRS score, stroke recurrence, medication compliance and
           laboratory examination including blood routine tests, liver functions and creatine
           kinase et al at 3 months, 6 months and 12 months after stroke onset. Additionally,
           patients are required to retake new HRMRI imaging of brain at 6 months.Remote patient
           education by We-Chat will be performed.

        5. Our study aims to explore the stroke mechanisms of symptomatic intracranial
           atherosclerosis, the dynamic changes under aggressive medical treatment and their
           associations with clinical events using conventional MRI sequences plus HR-MRI.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 14, 2018</start_date>
  <completion_date type="Anticipated">June 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>poor functional outcome</measure>
    <time_frame>90 day after stroke onset</time_frame>
    <description>The Rankin Score runs from 0-6, running from perfect health without symptoms to death. mRS 0-2 are defined as favorable outcomes while mRS 3-6 as unfavorable outcomes.0 - No symptoms.1 - No significant disability. Able to carry out all usual activities, despite some symptoms.2 - Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities.3 - Moderate disability. Requires some help, but able to walk unassisted.4 - Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted.5 - Severe disability. Requires constant nursing care and attention, bedridden, incontinent.6 - Dead.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants with stroke recurrence</measure>
    <time_frame>12 months after stroke onset</time_frame>
    <description>stroke recurrence with new lesions on DWI</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evolution of intracranial atherosclerosis burden</measure>
    <time_frame>6 months after stroke onset</time_frame>
    <description>Changes of plaque and thrombus volume on HR-MRI images at the admission and the follow-up</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with Death due to Heart Disease, Cerebravascular Disease or Other Vascular Etiology</measure>
    <time_frame>12 months after stroke onset</time_frame>
    <description>death due to stroke, intracranial hemorrhage,heart attack,heart failure, arrhythmia,pulmonary embolism,visceral hemorrhage or other vascular etiology</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Number of Participants with Adverse Events That Are Related to Anti-platelet Treatment</measure>
    <time_frame>12 months after stroke onset</time_frame>
    <description>intracranial bleeding confirmed by CT，fatal bleeding causing hemodynamic abnormalities needed blood tranfusion or surgical intervention</description>
  </other_outcome>
  <other_outcome>
    <measure>Number of Participants with Adverse Events That Are Related to StatinTreatment</measure>
    <time_frame>12 months after stroke onset</time_frame>
    <description>more than 3-fold liver enzyme increase，rhabdomyolysis</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">550</enrollment>
  <condition>Acute Ischemic Stroke AIS</condition>
  <condition>Intracranial Atherosclerosis ICAS</condition>
  <arm_group>
    <arm_group_label>Intracranial Atherosclerosis</arm_group_label>
    <description>First-ever stroke patients attributed to intracranial artery stenosis (&gt; 50% or occlusion) who receive aggressive medical management</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>aggressive medical management</intervention_name>
    <description>Aspirin (100 mg daily) and Clopidogrel (75 mg daily) for 3 months and Rosuvastatin (20mg daily) for at least 6 months as well as traditional risk factors management</description>
    <arm_group_label>Intracranial Atherosclerosis</arm_group_label>
    <other_name>Aspirin</other_name>
    <other_name>Clopidogrel</other_name>
    <other_name>Rosuvastatin</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        hospital based population
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 35-80 years old

          2. First-ever stroke patients confirmed by diffusion weighted imaging (DWI) attributed to
             intracranial artery stenosis (&gt; 50%) within 7 days after onset.

          3. Patients with stable vital signs.

          4. Patients who have underwent thrombolytic/intravascular therapy are allowed to enroll
             in the study.

        Exclusion Criteria:

          1. Patients with &gt; 50% ipsilateral carotid artery stenosis, cardiac embolism ,and any
             other stroke etiologies such as vasculitis, dissection or other causes.

          2. Patients with absolute/relative contraindication to MRI (including but not confined to
             metal in the body and claustrophobia).

          3. Patients who cannot comply with MRI exam.

          4. Patients who decline the consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Weihai Xu, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Peking Union Medical College Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Weihai Xu, MD</last_name>
    <phone>010-69156114</phone>
    <email>xuwh@pumch.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yining Huang, MD</last_name>
    <email>ynhuang@sina.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Beijing Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100010</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tao Gong</last_name>
      <phone>13718907701</phone>
      <email>gb20598@sina.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beijing Tongren Hospital Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100010</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jiawei Wang</last_name>
      <phone>18811612263</phone>
      <email>wangjwcq@1163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beijing Anzhen Hospital Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100020</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guangzhi Liu</last_name>
      <phone>13391777952</phone>
      <email>guangzhi2002@hotmali.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beijing Chao-Yang hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100020</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wenli Hu</last_name>
      <phone>13552983366</phone>
      <email>huwenli@sina.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>China-Japan Friendship Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100020</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dantao Peng</last_name>
      <phone>13910908579</phone>
      <email>18513415053@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beijing Friendship Hospital Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yongbo Zhang</last_name>
      <phone>13552909549</phone>
      <email>ybzhangcn@sina.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Peking University First Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yining Huang</last_name>
      <phone>13910432166</phone>
      <email>ynhuang@sina.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Hospital of Chinese Armed Police Forces</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100039</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shiwen Wu, MD</last_name>
      <phone>13910238117</phone>
      <email>neurowu@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Peking Union Medical College Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Weihai Xu, MD</last_name>
      <phone>010-69156372</phone>
      <email>xuwh@pumch.cn</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Peking University International Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>102200</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xianzeng Liu</last_name>
      <phone>13911879817</phone>
      <email>liuxianzeng@pkuih.edu.cn</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The first affiliated hospital affiliated to AMU (Southwest Hospital)</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zhenhua Zhou</last_name>
      <email>exploiter001@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fujian Medical University Union Hospital</name>
      <address>
        <city>Fuzhou</city>
        <state>Fujian</state>
        <zip>350001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Changyun Liu, MD</last_name>
      <phone>13365910778</phone>
      <email>13365910778@139.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Third Affiliated Hospital of Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510630</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zhengqi Lu</last_name>
      <phone>13570102668</phone>
      <email>lzq1828@aliyun.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The University of HongKong-Shenzhen Hospital</name>
      <address>
        <city>Shenzhen</city>
        <state>Guangdong</state>
        <zip>518000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xiaofan Chu</last_name>
      <email>chuxf@hku-szh.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hebei General Hospital</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Litao Li</last_name>
      <email>dingding51800@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Second Hospital of Hebei Medical University</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaoyun Liu</last_name>
      <email>AUDREY-L@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tangshan Gongren Hospital</name>
      <address>
        <city>Tangshan</city>
        <state>Hebei</state>
        <zip>063000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Baoquan Lu</last_name>
      <phone>13930565557</phone>
      <email>balcom@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hong Xinglong Central Hospital</name>
      <address>
        <city>Shuangyashan</city>
        <state>Heilongjiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Degang Sun</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nanshi Hospital of Nanyang</name>
      <address>
        <city>Nanyang</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xiaohua Xiao</last_name>
      <email>2207988910@qq.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Affiliated Taihe Hospital of Hubei University of Medicine</name>
      <address>
        <city>Shiyan</city>
        <state>Hubei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zhibing Ai</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tongji Hospital, Huazhong University of Science and Technology</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daishi Tian</last_name>
      <email>tiands@foxmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of University of South China</name>
      <address>
        <city>Hengyang</city>
        <state>Hunan</state>
        <zip>Hunan</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Subei People's Hospital of Jiangsu Province</name>
      <address>
        <city>Yangzhou</city>
        <state>Jiangsu</state>
        <zip>225001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jun Xu, MD</last_name>
      <phone>18051061768</phone>
      <email>13611572068@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>China-Japan Union Hospital, Jilin University</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Le Fang, MD</last_name>
      <email>drfangle@sina.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Hospital of Shen Yang Millitary Command</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110840</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Huishen Chen, MD</last_name>
      <phone>13352452086</phone>
      <email>chszh@aliyun.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>People's Hospital Ningxia Hui Autonomous Region</name>
      <address>
        <city>Yinchuan</city>
        <state>Ningxia</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhimin Shi</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shandong Provincial Hospital</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>JiNing NO.1 People Hospital</name>
      <address>
        <city>Jining</city>
        <state>Shandong</state>
        <zip>272000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhongrui Yan</last_name>
      <phone>18678769700</phone>
      <email>zhongruiy@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Qingdao Municipal Hospital</name>
      <address>
        <city>Qingdao</city>
        <state>Shandong</state>
        <zip>266000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jintai Yu</last_name>
      <email>yu-jintai@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Qilu Hospital of Shandong University (Qingdao)</name>
      <address>
        <city>Qingdao</city>
        <state>Shandong</state>
        <zip>266555</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Haifeng Li</last_name>
      <phone>18561810375</phone>
      <email>drlhf@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Weihai Municipal Hospital</name>
      <address>
        <city>Weihai</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Haixia Zhang</last_name>
      <email>371704058@qq.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200050</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jun Liu</last_name>
      <email>jly0520@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tongren Hospital, Shanghai Jiaotong University School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200050</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ailian Du</last_name>
      <email>lotusdu@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Changzhi People's Hospital</name>
      <address>
        <city>Changzhi</city>
        <state>Shanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lifang Zhang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Taiyuan Central Hospital of Shanxi Meidical University</name>
      <address>
        <city>Taiyuan</city>
        <state>Shanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Weirong Li</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>West China Hospital of Sichuan University</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bo Wu</last_name>
      <email>dr.bowu@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>First Affiliated Hospital of Zhejiang University</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hui Liang</last_name>
      <email>wen1937@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zhejiang Provincial Tongde Hospital</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xiaodong Zou</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Li ML, Xu WH, Song L, Feng F, You H, Ni J, Gao S, Cui LY, Jin ZY. Atherosclerosis of middle cerebral artery: evaluation with high-resolution MR imaging at 3T. Atherosclerosis. 2009 Jun;204(2):447-52. doi: 10.1016/j.atherosclerosis.2008.10.019. Epub 2008 Oct 25. Erratum in: Atherosclerosis. 2011 Jul;217(1):296.</citation>
    <PMID>19041971</PMID>
  </reference>
  <reference>
    <citation>Mazighi M, Labreuche J, Gongora-Rivera F, Duyckaerts C, Hauw JJ, Amarenco P. Autopsy prevalence of intracranial atherosclerosis in patients with fatal stroke. Stroke. 2008 Apr;39(4):1142-7. doi: 10.1161/STROKEAHA.107.496513. Epub 2008 Feb 28.</citation>
    <PMID>18309170</PMID>
  </reference>
  <reference>
    <citation>Xu WH, Li ML, Gao S, Ni J, Zhou LX, Yao M, Peng B, Feng F, Jin ZY, Cui LY. In vivo high-resolution MR imaging of symptomatic and asymptomatic middle cerebral artery atherosclerotic stenosis. Atherosclerosis. 2010 Oct;212(2):507-11. doi: 10.1016/j.atherosclerosis.2010.06.035. Epub 2010 Jun 25.</citation>
    <PMID>20638663</PMID>
  </reference>
  <reference>
    <citation>Xu WH, Li ML, Gao S, Ni J, Zhou LX, Yao M, Peng B, Feng F, Jin ZY, Cui LY. Plaque distribution of stenotic middle cerebral artery and its clinical relevance. Stroke. 2011 Oct;42(10):2957-9. doi: 10.1161/STROKEAHA.111.618132. Epub 2011 Jul 28.</citation>
    <PMID>21799160</PMID>
  </reference>
  <reference>
    <citation>Xu WH, Li ML, Gao S, Ni J, Yao M, Zhou LX, Peng B, Feng F, Jin ZY, Cui LY. Middle cerebral artery intraplaque hemorrhage: prevalence and clinical relevance. Ann Neurol. 2012 Feb;71(2):195-8. doi: 10.1002/ana.22626.</citation>
    <PMID>22367991</PMID>
  </reference>
  <reference>
    <citation>Xu WH, Li ML, Niu JW, Feng F, Jin ZY, Gao S. Intracranial artery atherosclerosis and lumen dilation in cerebral small-vessel diseases: a high-resolution MRI Study. CNS Neurosci Ther. 2014 Apr;20(4):364-7. doi: 10.1111/cns.12224. Epub 2014 Jan 15.</citation>
    <PMID>24423003</PMID>
  </reference>
  <reference>
    <citation>Xu WH, Li ML, Niu JW, Feng F, Jin ZY, Gao S. Deep tiny flow voids along middle cerebral artery atherosclerotic occlusions: a high-resolution MR imaging study. J Neurol Sci. 2014 Apr 15;339(1-2):130-3. doi: 10.1016/j.jns.2014.01.042. Epub 2014 Feb 6.</citation>
    <PMID>24530171</PMID>
  </reference>
  <reference>
    <citation>Li M, Wu SW, Xu WH. High-resolution MRI of radiation-induced intracranial vasculopathy. Neurology. 2015 Feb 10;84(6):631. doi: 10.1212/WNL.0000000000001223.</citation>
    <PMID>25666631</PMID>
  </reference>
  <reference>
    <citation>Derdeyn CP, Chimowitz MI, Lynn MJ, Fiorella D, Turan TN, Janis LS, Montgomery J, Nizam A, Lane BF, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Lynch JR, Zaidat OO, Rumboldt Z, Cloft HJ; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet. 2014 Jan 25;383(9914):333-41. doi: 10.1016/S0140-6736(13)62038-3. Epub 2013 Oct 26.</citation>
    <PMID>24168957</PMID>
  </reference>
  <reference>
    <citation>Xu YY, Li ML, Gao S, Hou B, Sun ZY, Zhou HL, Feng F, Xu WH. Non-moyamoya vessel network formation along steno-occlusive middle cerebral artery. Neurology. 2016 May 24;86(21):1957-63. doi: 10.1212/WNL.0000000000002698. Epub 2016 Apr 27.</citation>
    <PMID>27164677</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>October 22, 2018</study_first_submitted>
  <study_first_submitted_qc>October 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 25, 2018</study_first_posted>
  <last_update_submitted>March 28, 2020</last_update_submitted>
  <last_update_submitted_qc>March 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Peking Union Medical College Hospital</investigator_affiliation>
    <investigator_full_name>Wei-Hai Xu</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Acute Ischemic Stroke</keyword>
  <keyword>Intracranial Atherosclerosis ICAS</keyword>
  <keyword>HRMRI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Intracranial Arteriosclerosis</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aspirin</mesh_term>
    <mesh_term>Clopidogrel</mesh_term>
    <mesh_term>Rosuvastatin Calcium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

